Aerion Bioscience

1 known investors

Aerion Bioscience develops a non-invasive blood test that uses a 6-protein biomarker panel and an algorithm to detect early-stage lung cancer in high-risk individuals. The company operates in the cancer diagnostics field and is expanding clinical testing to distinguish lung cancer stages and other lung conditions such as COPD.

BiotechDigital HealthMedical Devices